Doxycycline hyclate delayed released
Phase 3Small molecule
Doxycycline hyclate delayed released is one of 9 small molecule programs targeting Gonorrhea. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
10 competitors in Gonorrhea
#DrugCompanyPhaseTrials
1Cipro
BayerApproved
Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Garamycin
SSchering-Plough
Approved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Approved
Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Factive
LLG Chem
Approved
Doxycycline hyclate delayed released
WWestat
Phase 3
Menacwy Liquid
GSKPreclinical
Trumenba
PfizerPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]